Remark Holdings, Inc. (MARK) Reaches $7.95 After 4.00% Down Move; Marrone Bio Innovations Has 0.78 Sentiment

February 15, 2018 - By Ellis Scott

The stock of Remark Holdings, Inc. (NASDAQ:MARK) is a huge mover today! The stock decreased 6.25% or $0.53 during the last trading session, reaching $7.95. About 805,032 shares traded. Remark Holdings, Inc. (NASDAQ:MARK) has declined 33.48% since February 15, 2017 and is downtrending. It has underperformed by 50.18% the S&P500.The move comes after 8 months negative chart setup for the $217.22 million company. It was reported on Feb, 15 by Barchart.com. We have $7.63 PT which if reached, will make NASDAQ:MARK worth $8.69 million less.

Marrone Bio Innovations, Inc. provides bio pest management and plant health products primarily for agricultural and water markets in the United States and internationally. The company has market cap of $36.05 million. It offers herbicides; fungicides; nematicides; insecticides; algaecides for algae control; molluscicides for mussel and snail control; plant growth and stress regulators; and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation. It currently has negative earnings. The companyÂ’s products include Regalia, a plant extract fungicidal biopesticide for plant disease control and plant health; and Grandevo, a bioinsecticide for insect and mite control to the growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens, and ornamental plants.

Since January 1, 0001, it had 1 insider buy, and 0 sales for $5.00 million activity.

The stock decreased 2.54% or $0.03 during the last trading session, reaching $1.15. About 16,242 shares traded. Marrone Bio Innovations, Inc. (MBII) has risen 94.03% since February 15, 2017 and is uptrending. It has outperformed by 77.33% the S&P500.

Ardsley Advisory Partners holds 0.56% of its portfolio in Marrone Bio Innovations, Inc. for 3.68 million shares. Waddell & Reed Financial Inc owns 4.71 million shares or 0.01% of their US portfolio. Moreover, A.R.T. Advisors Llc has 0% invested in the company for 23,171 shares. The Michigan-based Azimuth Capital Management Llc has invested 0% in the stock. Blackrock Inc., a New York-based fund reported 75,948 shares.

Analysts await Marrone Bio Innovations, Inc. (NASDAQ:MBII) to report earnings on April, 4. They expect $-0.21 EPS, up 34.38% or $0.11 from last year’s $-0.32 per share. After $-0.27 actual EPS reported by Marrone Bio Innovations, Inc. for the previous quarter, Wall Street now forecasts -22.22% EPS growth.

Analysts await Remark Holdings, Inc. (NASDAQ:MARK) to report earnings on March, 29. They expect $-0.25 earnings per share, up 37.50% or $0.15 from last year’s $-0.4 per share. After $-0.41 actual earnings per share reported by Remark Holdings, Inc. for the previous quarter, Wall Street now forecasts -39.02% EPS growth.

Remark Holdings, Inc. owns, operates, and acquires digital media properties across multiple verticals that deliver content worldwide. The company has market cap of $217.22 million. The firm leverages its digital media assets to target the Millennial demographic, which provides it with access to markets. It currently has negative earnings. It operates KanKan, a social media application and data intelligence platform, which aggregates content and consumer-shopping data across social media platforms; Vegas.com that offers users the ability to book lodging, air travel, show tickets, and tours; and Roomlia, a mobile hotel-booking application.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: